Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and hormonal therapy in advanced hormone-naive prostate cancer
NCT00796458Phase 3Unknown
- Sponsor
- AOU San Giovanni Battista di Torino
- Start
- Apr 2005
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in prostate cancer (PCa), sponsored by AOU San Giovanni Battista di Torino. Status: unknown.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00796458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00796458.